ANIP ANI Pharmaceuticals, Inc.
Healthcare$82.72-0.06%ClosedMarket Cap: $1.88B
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
0
Dispositions
7
Buy/Sell Ratio
0.00
Net Shares
-73,204
Shares Acquired
0
Shares Disposed
73,204
Total Bought ($)
$0.00
Total Sold ($)
$7.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed May 13 | Walsh Patrick D | director | Sell | 10,000 | $80.63 | 38,432 |
| Wed May 13 | Walsh Patrick D | director | Sell | 3,973 | $80.75 | 48,432 |
| Wed May 13 | Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | Sell | 459 | $79.21 | 38,271 |
| Wed May 13 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | Sell | 55,000 | $77.57 | 349,889 |
| Wed May 13 | Gutwerg Ori | officer: SVP, GENERICS | Sell | 2,772 | $79.50 | 78,696 |
| Wed May 13 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $78.16 | 78,390 |
| Mon Apr 13 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $77.95 | 78,890 |
| Fri Mar 13 | Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | Sell | 4,772 | $74.91 | 38,730 |
| Fri Mar 13 | Mutz Christopher | officer: HEAD OF RARE DISEASE | Sell | 3,162 | $71.64 | 91,309 |
| Fri Mar 13 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $72.62 | 79,390 |
| Tue Mar 10 | Mutz Christopher | officer: HEAD OF RARE DISEASE | Sell | 3,602 | $74.18 | 94,471 |
| Tue Mar 10 | Mutz Christopher | officer: HEAD OF RARE DISEASE | Sell | 2,121 | $74.22 | 101,387 |
| Tue Mar 10 | Mutz Christopher | officer: HEAD OF RARE DISEASE | Sell | 3,314 | $74.04 | 98,073 |
| Tue Mar 10 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | Sell | 17,060 | $74.04 | 404,889 |
| Tue Mar 10 | Gutwerg Ori | officer: SVP, GENERICS | Sell | 3,314 | $74.04 | 81,468 |